Interestingly, the expression levels of OIP5-AS1 and PD-L1 were both elevated along with disease severity increase, indicating that OIP5-AS1 and PD-L1 may promote the progression of NSCLC [28,29, 30]. Here, OIP5 is linked to non-small cell lung carcinoma.